Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Marta Sokolowska"'
Publikováno v:
Sensors, Vol 23, Iss 12, p 5424 (2023)
Thispaper compares the usability of various Apple MacBook Pro laptops were tested for basic machine learning research applications, including text-based, vision-based, and tabular data. Four tests/benchmarks were conducted using four different MacBoo
Externí odkaz:
https://doaj.org/article/f055ba58f4d94125b2911cf9d45aec66
Publikováno v:
Sensors; Volume 23; Issue 12; Pages: 5424
Thispaper compares the usability of various Apple MacBook Pro laptops were tested for basic machine learning research applications, including text-based, vision-based, and tabular data. Four tests/benchmarks were conducted using four different MacBoo
Autor:
Isabella Szeto, Marie-Henriette Eerdekens, Robert Nemeth, Elke Kleideiter, Karin Göhler, Marta Sokolowska, Kerri A. Schoedel
Publikováno v:
Journal of Clinical Psychopharmacology. 39:46-56
Background Cebranopadol is a nociceptin/orphanin FQ peptide/opioid receptor agonist with central antinociceptive activity. We hypothesize that this novel mechanism of action may lead to a lower risk of abuse compared with pure μ-opioid peptide recep
Autor:
Suzanne K. Vosburg, Jeremiah J. Trudeau, Marta Sokolowska, Thomas A. Eaton, Judy Ashworth, Michelle Muffett-Lipinski, Nathaniel P. Katz, Eric Osgood
Publikováno v:
Journal of Child & Adolescent Substance Abuse. 25:105-112
The progression from prescription opioid (RXO) abuse to RXO addiction is not well understood in adolescents, nor is the progression from RXO addiction to heroin abuse. The purpose of this pilot study was to characterize the development of RXO drug ab
Publikováno v:
The Journal of Clinical Pharmacology. 56:657-659
Publikováno v:
Human Psychopharmacology: Clinical and Experimental. 29:251-265
Objective This paper aimed to evaluate the effects of coadministered immediate-release morphine and ethanol on safety, pharmacokinetic, and pharmacodynamic measures. Methods In the first stage of a randomized, double-blind, placebo-controlled, crosso
Autor:
Sharon Hertz, Michael Klein, Gary M. Reisfield, James P. Zacny, George E. Bigelow, Laurie B. Burke, Shannon M. Smith, Robert D. Colucci, Ernest A. Kopecky, Sharon L. Walsh, Cristina Sampaio, Srinivasa N. Raja, Robert L. Balster, Richard A. Denisco, John T. Farrar, Edgar H. Adams, Edward J. Cone, Bob A. Rappaport, Deborah B. Leiderman, Pamela Palmer, Beatrice Setnik, Sandra D. Comer, Dennis C. Turk, Nathaniel P. Katz, Penney Cowan, Jennifer A. Haythornthwaite, Richard W. Foltin, Joseph W. Stauffer, Michael P. McDermott, Michael C. Rowbotham, Kelly Posner, Robert H. Dworkin, Marta Sokolowska, Alec B. O'Connor, Charles A. O'Brien, Christine Rauschkolb, J. David Haddox, Roderick Junor, Gary W. Jay
Publikováno v:
Pain. 154:2324-2334
Assessing and mitigating the abuse liability (AL) of analgesics is an urgent clinical and societal problem. Analgesics have traditionally been assessed in randomized clinical trials (RCTs) designed to demonstrate analgesic efficacy relative to placeb
Publikováno v:
Pain practice : the official journal of World Institute of Pain. 16(7)
Autor:
Marco Pappagallo, Marta Sokolowska
Publikováno v:
Postgraduate Medicine. 124:101-109
Because rates of both opioid prescribing and opioid abuse have increased, drug companies have responded by considering strategies to make opioid formulations less attractive for abuse without compromising safety or efficacy for patients with legitima
Autor:
Marta Sokolowska, Suzanne K. Vosburg
This chapter reviews the conduct of the human abuse potential study from the regulatory perspective, as outlined in the Food and Drug Administration (FDA)'s 2010 Guidance for Industry: Assessment of Abuse Potential of Drugs. Using the guidance as an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::134eb0ac6373f4f42472ecd836be5735
https://doi.org/10.1016/b978-0-12-420172-9.00009-6
https://doi.org/10.1016/b978-0-12-420172-9.00009-6